Cargando…

Bevacizumab: Diffuse alveolar haemorrhage: case report

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149143/
http://dx.doi.org/10.1007/s40278-015-8207-2
_version_ 1783520747113676800
collection PubMed
description
format Online
Article
Text
id pubmed-7149143
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71491432020-04-13 Bevacizumab: Diffuse alveolar haemorrhage: case report Reactions Weekly Case Report Springer International Publishing 2015-03-07 2015 /pmc/articles/PMC7149143/ http://dx.doi.org/10.1007/s40278-015-8207-2 Text en © Springer International Publishing Switzerland 2015 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Bevacizumab: Diffuse alveolar haemorrhage: case report
title Bevacizumab: Diffuse alveolar haemorrhage: case report
title_full Bevacizumab: Diffuse alveolar haemorrhage: case report
title_fullStr Bevacizumab: Diffuse alveolar haemorrhage: case report
title_full_unstemmed Bevacizumab: Diffuse alveolar haemorrhage: case report
title_short Bevacizumab: Diffuse alveolar haemorrhage: case report
title_sort bevacizumab: diffuse alveolar haemorrhage: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149143/
http://dx.doi.org/10.1007/s40278-015-8207-2